Fischer Medical, a company based outside of Denver, Colorado, won FDA clearance for its BLOOM2 cardiac electrophysiology stimulator. The all-digital device provides a fresh interface over the original Bloom, the design of which has withstood over 40 years. The new BLOOM2 takes design cues from the classic machine, helping EP docs and staff to easily transition to the digital model.
Protocols commonly used by a physician can be pre-programmed to easily pull up as necessary, and can be modified on a per-case basis. While the setups are done on the touchscreen, more traditional looking switches are used during procedures.
“The Bloom2 represents years of research and development to integrate the key components of what made the original Bloom the market leading stimulator worldwide,” said Wes Rogers, President & CEO of Fischer Medical. “The Bloom2 is the only stimulator on the market that offers the tactile feel of the original Bloom combined with a state-of-the-art user interface.”
Product page: BLOOM2…
Via: Fischer Medical…